OTCMKTS:NBIO

Nascent Biotech Stock Signals

etoro logo Buy NBIO
*Your capital is at risk
$0.0002
+0 (+0%)
At Close: Jul 10, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for Nascent Biotech, Inc.

General

Signal Type Signal Value Data
Score 0.000 111 days ( 33.33 %
Last Price $0.0002 0 %
Performance History
7 Days
$0.0003 $0.0002
-33.33%
30 Days
$0.0004 $0.0002
-50.00%
12 Mos
$0.0003 $0.0002
-33.33%

7/18

Active Buy Signals

Specific Signals

Short Term
Net score: 44.59
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.0002 - $0.0002
Trend - 3 mos 12.87 % High Width: 105.37 %
Pred. range - 3 mos $0.0002 - $0.0005 Low 13.30 % - 132.69 %
Volume Direction Sell High Volume: 23 · Direction: 0
Pivot Short Buy Very Low Jul 09, 2026 - 2 days
RSI Short Pivot Signal Sell Very Low Nov 30, -0001 - N/A days
Short MA 3 mos Buy Low May 07, 2026 - 44 days
Long MA 3 mos Sell Medium Jun 16, 2026 - 17 days
Short/Long MA 3 mos Sell Medium Jun 24, 2026 - 12 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 31.1
Signal Type Signal Value Importance Data
Trend - 12 mos -6.69 % Very High Width: 1,578.01 %
Pred. range - 12 mos N/A - $0.0749 High -100.00 % - 37,337.28 %
Short MA 12 mos Sell Very High Jun 16, 2026 - 17 days
Long MA 12 mos Sell Very High Jun 16, 2026 - 17 days
Short/Long MA 12 mos Buy Very High Jun 02, 2026 - 27 days
Pivot Long Buy Low Jul 09, 2026 - 2 days
RSI Long Pivot Signal Buy Low Feb 10, 2026 - 104 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Sell High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT NASCENT BIOTECH, INC.
Nascent Biotech
Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. In addition, the company is developing MultiPharm, a proprietary technology platfo...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE